Interplay between JA, SA and ABA signalling during basal and induced resistance against Pseudomonas syringae and Alternaria brassicicola.
We have examined the role of the callose synthase PMR4 in basal resistance and beta-aminobutyric acid-induced resistance (BABA-IR) of Arabidopsis thaliana against the hemi-biotrophic pathogen Pseudomonas syringae and the necrotrophic pathogen Alternaria brassicicola. Compared to wild-type plants, the pmr4-1 mutant displayed enhanced basal resistance against P. syringae, which correlated with constitutive expression of the PR-1 gene. Treating the pmr4-1 mutant with BABA boosted the already elevated levels of PR-1 gene expression, and further increased the level of resistance. Hence, BABA-IR against P. syringae does not require PMR4-derived callose. Conversely, pmr4-1 plants showed enhanced susceptibility to A. brassicicola, and failed to show BABA-IR. Wild-type plants showing BABA-IR against A. brassicicola produced increased levels of JA. The pmr4-1 mutant produced less JA upon A. brassicicola infection than the wild-type. Blocking SA accumulation in pmr4-1 restored basal resistance, but not BABA-IR against A. brassicicola. This suggests that the mutant's enhanced susceptibility to A. brassicicola is caused by SA-mediated suppression of JA, whereas the lack of BABA-IR is caused by its inability to produce callose. A. brassicicola infection suppressed ABA accumulation. Pre-treatment with BABA antagonized this ABA accumulation, and concurrently potentiated expression of the ABA-responsive ABI1 gene. Hence, BABA prevents pathogen-induced suppression of ABA accumulation, and sensitizes the tissue to ABA, causing augmented deposition of PMR4-derived callose.
Flors
Victor
V
Laboratory of Molecular and Cellular Biology, Institute of Botany, University of Neuchâtel, Rue Emile-Argand 11, Case Postale 158, 2009 Neuchâtel, Switzerland.
Ton
Jurriaan
J
van Doorn
Ronald
R
Jakab
Gabor
G
García-Agustín
Pilar
P
Mauch-Mani
Brigitte
B
D000040:Abscisic Acid / Q000378:metabolism* / Q000494:pharmacology; D000528:Alternaria / Q000502:physiology*; D000613:Aminobutyrates / Q000494:pharmacology; D017360:Arabidopsis / Q000187:drug effects / Q000382:microbiology*; D029681:Arabidopsis Proteins / Q000235:genetics / Q000378:metabolism; D003517:Cyclopentanes / Q000378:metabolism*; D018506:Gene Expression Regulation, Plant / Q000502:physiology; D005936:Glucans / Q000378:metabolism; D005964:Glucosyltransferases / Q000235:genetics / Q000378:metabolism; D054884:Host-Pathogen Interactions; D009154:Mutation; D054883:Oxylipins / Q000378:metabolism*; D010935:Plant Diseases / Q000382:microbiology*; D044224:Pseudomonas syringae / Q000502:physiology*; D020156:Salicylic Acid / Q000378:metabolism*; D015398:Signal Transduction / Q000502:physiology
D000613:Aminobutyrates; D029681:Arabidopsis Proteins; D003517:Cyclopentanes; D005936:Glucans; D054883:Oxylipins; C047667:3-aminobutyric acid; C011006:jasmonic acid; D000040:Abscisic Acid; C048306:callose; D005964:Glucosyltransferases; C020570:1,3-beta-glucan synthase; D020156:Salicylic Acid